Products - Mesothelioma | Topic | NICE

Showing 1 product

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Pembrolizumab with pemetrexed and platinum-based chemotherapy for untreated unresectable advanced malignant pleural mesothelioma (terminated appraisal) (TA1125)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 January 2026